Eli Lilly will offer more doses of its obesity drug Zepbound in vials and lower the prices of the doses it already sells ...

While some NIH study sections will resume, advisory council meetings, which make final funding decisions, seem to still be ...

Eli Lilly said Tuesday that it will offer more doses of its obesity drug Zepbound in vials and lower the prices of the doses ...

Heightened security at UnitedHealth Group's Minnesota headquarters in the wake of a top executive’s killing is the most ...

Native American leaders were taken aback to see 22% fewer American Indian or Alaska Native medical students enrolled last ...

Legislatures, governors, government agencies, and plaintiff attorneys are taking action against ultra-processed foods, but ...

Just as college sports have had to change, so does basic science research at universities. Morris W. Foster of the School for ...

As biosimilar versions of a big-selling Johnson & Johnson medicine reach the U.S. market, the health care giant accused one ...

Hi! Good to see ya. An ER doctor in Chicago told the New York Times last week that he sees “Croc-specific injuries” once a ...

The hiring of a former top FDA official amplifies "revolving door" criticism at the worst possible time, STAT's Adam ...

A small study on Covid vaccine safety has sparked an online tempest — and highlighted the conundrum faced by some scientists.

Patrizia Cavazzoni, formerly the top regulator of the drug division of the FDA, will join Pfizer as chief medical officer.